Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
CHM-1101 by Chimeric Therapeutics for Astrocytoma: Likelihood of Approval
CHM-1101 is under clinical development by Chimeric Therapeutics and currently in Phase I for Astrocytoma. According to GlobalData, Phase I...
CHM-1101 by Chimeric Therapeutics for Malignant Glioma: Likelihood of Approval
CHM-1101 is under clinical development by Chimeric Therapeutics and currently in Phase I for Malignant Glioma. According to GlobalData, Phase...
CHM-1101 by Chimeric Therapeutics for Recurrent Glioblastoma Multiforme (GBM): Likelihood of Approval
CHM-1101 is under clinical development by Chimeric Therapeutics and currently in Phase I for Recurrent Glioblastoma Multiforme (GBM). According to...